Shoulder Innovations, Inc.

Shoulder Innovations, Inc.

17.30
EUR
-0.90
(-4.95%)
-1.43EPS
Mar 16Next Earn
Shoulder Innovations, Inc.
GETTEX:A41EEL
(Gettex)

Recent

price

17.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2023
2024
2025
TTM
USD
0.96
1.57
5.48
3.13
Revenue per Share
-0.63
-0.78
-4.68
-1.62
Basic EPS, GAAP
-0.79
-0.9
-4.17
-2.07
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
-1.97
-2.72
6.86
5.69
Book Value per Share
-2.01
-2.74
6.85
5.69
Tangible Book Value per Share
20
20
9
21
Basic Weighted Avg Shares
19
32
47
64
Sales/Revenue/Turnover
-56.37
-46.34
-55.58
-54.44
Operating Margin (%)
2
2
3
4
Depreciation Expense
-13
-16
-40
-33
Net Income, GAAP
- -
- -
- -
- -
Effective Tax Rate (%)
-65.66
-49.39
-85.29
-51.72
Profit Margin (%)
44
27
143
119
Working Capital
14
15
15
15
LT Debt
-40
-55
141
118
Total Equity
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-25.05
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
15
15
15
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
146
137
131
Cash, Cash Equivalents & STI
109
99
92
Accounts Receivable, Net
11
11
9
Inventories
22
23
24
Total Current Liabilities
12
13
12
Payables & Accruals
11
12
11
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-357.34%
Free Cash Flow
- -
- -
98.37%
Net Income, GAAP
- -
- -
158.4%
Sales/Revenue/Turnover
- -
- -
49.63%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7
8
7
9
32
2025
10
11
12
14
47
2026
17
17
16
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.18
-0.21
-0.2
-0.19
-0.78
2025
-0.23
-0.95
-0.64
-0.38
-4.68
2026
-0.41
-0.49
-0.34
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Shoulder Innovations, Inc. Shoulder Innovations, Inc. (NYSE: SI) is a commercial-stage medical technology company that designs, develops, manufactures, and distributes advanced implant systems for shoulder arthroplasty, including anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA), primarily in the United States. The company offers its proprietary InSet Glenoid technology, which reduces mechanical stress at the bone-implant interface to enhance fixation, stability, and longevity while addressing the rocking horse effect; InSet Total Shoulder System; InSet Reverse Shoulder System with a lateralized-lateralized design for improved range of motion and fewer complications; InSet 70 humeral stem; ProVoyance Shoulder preoperative planning software; and streamlined Dual Tray and Reverse Tray systems optimized for hospital and ambulatory surgery center efficiency. Founded in 2009 by Dr. Steve Gunther and EDF Ventures and headquartered at 1535 Steele Avenue SW, Suite B, Grand Rapids, Michigan, the company targets orthopedic surgeons and patients requiring shoulder replacement solutions amid a growing $2.8 billion global market. Recent developments include the full commercial launch of the InSet 70 humeral stem in September 2025; a $40 million convertible notes financing closed in July 2025 led by Fidelity Management & Research Company to support commercialization and product development; completion of an initial public offering in July 2025 raising $75 million in gross proceeds; expansion of its surgeon customer base by nearly 50% year-over-year; and third-quarter 2025 revenue growth of 58% to $11.8 million, with full-year guidance raised to $42-44 million representing 33-39% growth.

Company News

  • Shoulder Innovations Doubles Customer Growth, Sets Sights on Surgical Robotics

  • Does Shoulder Innovations, Inc. (SI) Have the Potential to Rally 25.24% as Wall Street Analysts Expect?

  • Shoulder Innovations, Inc. (SI) Presents at 2026 UBS Global Healthcare Conference Transcript

  • Here's Why Shoulder Innovations, Inc. (SI) is a Great Momentum Stock to Buy

  • What Shoulder Innovations (SI) Said on Its Q3 Earnings Call

  • Shoulder Innovations, Inc. (SI) Q3 2026 Earnings Call Transcript

  • Shoulder Innovations, Inc. (SI) Reports Q3 Loss, Misses Revenue Estimates

  • Shoulder Innovations Reports Third Quarter 2026 Financial Results and Raises Full Year Outlook

  • COPE Health Solutions Named Finalist in CMS QualTech for Super Intelligence (SI) Solution to Expand Medicare Annual Wellness Visits

  • Shoulder Innovations to Participate in Upcoming Investor Conferences

  • BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategy

  • SpaceX (SPCX) Reports Strong Q3 Results and Positive Revenue Guidance

  • 3M and AWS collaborate to advance optical connectivity innovation

  • Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026

  • BlockchAIn Digital Infrastructure Says Nebius Prepayment Funds $800M Data Center Build

  • Shoulder Innovations Initiates Commercial Launch of the InSet® Go

  • Shoulder Innovations, Inc. (NYSE:SI) Stock Has Average Target Price of $25.50

  • Squarepoint Ops LLC Invests $896,000 in Shoulder Innovations, Inc. $SI

  • Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

  • Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch